News Teva settles Oklahoma opioid lawsuit ahead of trial Teva has opted to settle the first trial among hundreds of cases that accuse it and other drugmakers of helping to fuel the opioid addiction epidemic in the US.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
